{"count": 6, "results": [{"_id": "18791454", "pmid": 18791454, "title": "Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.", "journal": "Transplantation", "authors": ["Yi T", "Rao DA", "Tang PC", "Wang Y", "Cuchara LA", "Bothwell AL", "Colangelo CM", "Tellides G", "Pober JS", "Lorber MI"], "date": "2008-09-15T00:00:00Z", "doi": "10.1097/TP.0b013e318183eefa", "meta_date_publication": "2008 Sep 15", "meta_volume": "86", "meta_issue": "5", "meta_pages": "719-27", "score": 50063.65, "text_hl": "The effects of statins on T-cell alloresponses to vascular endothelial cells were also investigated in vitro. RESULTS: @<m>DISEASE_Arteriosclerosis</m> @DISEASE_MESH:D001161 @@@Graft arteriosclerosis@@@-like @DISEASE_Carotid_Artery_Injuries @DISEASE_MESH:D020212 @@@arteriopathy@@@ induced by PBMCs was reduced by @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ at 30 mg/kg/day or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ at 100 mg/kg/day that correlated with decreased graft-infiltrating CD3+ T cells. ", "citations": {"NLM": "Yi T, Rao DA, Tang PC, Wang Y, Cuchara LA, Bothwell AL, Colangelo CM, Tellides G, Pober JS, Lorber MI. Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells. Transplantation. 2008 Sep 15;86(5):719-27. PMID: 18791454", "BibTeX": "@article{18791454, title={Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells.}, author={Yi T and Rao DA and Tang PC and Wang Y and Cuchara LA and Bothwell AL and Colangelo CM and Tellides G and Pober JS and Lorber MI}, journal={Transplantation}, volume={86}, number={5}, pages={719-27}}"}}, {"_id": "19583932", "pmid": 19583932, "title": "[Color Doppler ultrasound evaluation of a Chinese herbal formula in treating lower limb arteriosclerosis: a randomized controlled trial].", "journal": "Zhong Xi Yi Jie He Xue Bao", "authors": ["Tong XJ", "Xiang XY", "Cheng ZH", "Chen L", "Chen XC", "Chen JX"], "date": "2009-06-01T00:00:00Z", "doi": "10.3736/jcim20090605", "meta_date_publication": "2009 Jun", "meta_volume": "7", "meta_issue": "6", "meta_pages": "518-21", "score": 50061.395, "text_hl": "[Color Doppler ultrasound evaluation of a Chinese herbal formula in treating lower @<m>DISEASE_Arteriosclerosis</m> @DISEASE_MESH:D001161 @@@limb arteriosclerosis@@@: a randomized controlled trial].", "citations": {"NLM": "Tong XJ, Xiang XY, Cheng ZH, Chen L, Chen XC, Chen JX. [Color Doppler ultrasound evaluation of a Chinese herbal formula in treating lower limb arteriosclerosis: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao. 2009 Jun;7(6):518-21. PMID: 19583932", "BibTeX": "@article{19583932, title={[Color Doppler ultrasound evaluation of a Chinese herbal formula in treating lower limb arteriosclerosis: a randomized controlled trial].}, author={Tong XJ and Xiang XY and Cheng ZH and Chen L and Chen XC and Chen JX}, journal={Zhong Xi Yi Jie He Xue Bao}, volume={7}, number={6}, pages={518-21}}"}}, {"_id": "27281490", "pmid": 27281490, "pmcid": "PMC4906137", "title": "Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial", "journal": "Redox Biol", "authors": ["Rasmussen ST", "Andersen JT", "Nielsen TK", "Cejvanovic V", "Petersen KM", "Henriksen T", "Weimann A", "Lykkesfeldt J", "Poulsen HE"], "date": "2016-10-01T00:00:00Z", "doi": "10.1016/j.redox.2016.05.007", "meta_date_publication": "2016 Oct", "meta_volume": "9", "meta_issue": "", "meta_pages": "32-38", "score": 50056.14, "text_hl": "In addition, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment leads to a reduction in fluxes in mitochondrial respiratory complexes I and II and might thereby reduce the formation of @CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@reactive oxygen species@@@, which have been implicated in the pathogenesis of @<m>DISEASE_Arteriosclerosis</m> @DISEASE_MESH:D001161 @@@arteriosclerosis@@@. ", "citations": {"NLM": "Rasmussen ST, Andersen JT, Nielsen TK, Cejvanovic V, Petersen KM, Henriksen T, Weimann A, Lykkesfeldt J, Poulsen HE. Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial Redox Biol. 2016 Oct;9():32-38. PMID: 27281490", "BibTeX": "@article{27281490, title={Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial}, author={Rasmussen ST and Andersen JT and Nielsen TK and Cejvanovic V and Petersen KM and Henriksen T and Weimann A and Lykkesfeldt J and Poulsen HE}, journal={Redox Biol}, volume={9}, pages={32-38}}"}}, {"_id": "25780437", "pmid": 25780437, "pmcid": "PMC4353769", "title": "Effect of polycan, a beta-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model", "journal": "Exp Ther Med", "authors": ["Lim MK", "Ku SK", "Choi JS", "Kim JW"], "date": "2015-04-01T00:00:00Z", "doi": "10.3892/etm.2015.2238", "meta_date_publication": "2015 Apr", "meta_volume": "9", "meta_issue": "4", "meta_pages": "1369-1378", "score": 50052.785, "text_hl": "In the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIMVA@@@-treated group, body weight (P<0.05), the serum level of @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@ (@CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglyceride@@@, T-CHOL and LDL; P<0.01) and the level of @<m>DISEASE_Arteriosclerosis</m> @DISEASE_MESH:D001161 @@@arteriosclerosis@@@ (P<0.01) were significantly reduced when compared with the vehicle control group. ", "citations": {"NLM": "Lim MK, Ku SK, Choi JS, Kim JW. Effect of polycan, a beta-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model Exp Ther Med. 2015 Apr;9(4):1369-1378. PMID: 25780437", "BibTeX": "@article{25780437, title={Effect of polycan, a beta-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model}, author={Lim MK and Ku SK and Choi JS and Kim JW}, journal={Exp Ther Med}, volume={9}, number={4}, pages={1369-1378}}"}}, {"_id": "15836008", "pmid": 15836008, "title": "A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain.", "journal": "Pharmacoeconomics", "authors": ["Tárraga-López PJ", "Celada-Rodríguez A", "Cerdán-Oliver M", "Solera-Albero J", "Ocaña-López JM", "López-Cara MA", "De Miguel-Clave J"], "date": "2005-01-01T00:00:00Z", "doi": "10.2165/00019053-200523030-00007", "meta_date_publication": "2005", "meta_volume": "23", "meta_issue": "3", "meta_pages": "275-87", "score": 50045.438, "text_hl": "MAIN MEASUREMENTS AND RESULTS: After 6 months, the therapeutic goals of LDL-C control, according to the recommendations of the Spanish Society of @<m>DISEASE_Arteriosclerosis</m> @DISEASE_MESH:D001161 @@@Arteriosclerosis@@@--Consensus-2000, were reached in 62.5%, 43.8%, 45.5% and 40.5% of @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, respectively. ", "citations": {"NLM": "Tárraga-López PJ, Celada-Rodríguez A, Cerdán-Oliver M, Solera-Albero J, Ocaña-López JM, López-Cara MA, De Miguel-Clave J. A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain. Pharmacoeconomics. 2005;23(3):275-87. PMID: 15836008", "BibTeX": "@article{15836008, title={A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain.}, author={Tárraga-López PJ and Celada-Rodríguez A and Cerdán-Oliver M and Solera-Albero J and Ocaña-López JM and López-Cara MA and De Miguel-Clave J}, journal={Pharmacoeconomics}, volume={23}, number={3}, pages={275-87}}"}}, {"_id": "7494938", "pmid": 7494938, "title": "[The pharmacological treatment of hypercholesterolemia].", "journal": "Rev Esp Cardiol", "authors": ["Pérez Jiménez F"], "date": "1995-01-01T00:00:00Z", "meta_date_publication": "1995", "meta_volume": "48 Suppl 5", "meta_issue": "", "meta_pages": "31-8", "score": 50040.227, "text_hl": "Comparing the three statin drugs, @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, the latter has recently been shown in study 4S to be effective in reducing global and coronary mortality in @SPECIES_9606 @@@patients@@@ with a history of @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@. ", "citations": {"NLM": "Pérez Jiménez F. [The pharmacological treatment of hypercholesterolemia]. Rev Esp Cardiol. 1995;48 Suppl 5():31-8. PMID: 7494938", "BibTeX": "@article{7494938, title={[The pharmacological treatment of hypercholesterolemia].}, author={Pérez Jiménez F}, journal={Rev Esp Cardiol}, volume={48 Suppl 5}, pages={31-8}}"}}]}